News | January 31, 2026
Eli Lilly announces $3.5 billion Pennsylvania manufacturing hub
The facility will bring 850 high-value jobs to the region, including engineers, scientists, operations personnel, and lab technicians
The facility will bring 850 high-value jobs to the region, including engineers, scientists, operations personnel, and lab technicians
UK Prime Minister Keir Starmer praised the initiative, saying: “Unlocking opportunities for British businesses across the globe and delivering for working people back home is always the driving force behind my international engagements."
The Tanuku facility will focus on the production of key therapeutic APIs, including Anti-Tussive, Anti-Coagulant (Blood Thinner), Anaesthetic, and Antidepressant molecules
The deal brings three high-quality small-molecule drug substance sites into Siegfried’s portfolio
Growth across inorganic & organic chemicals, fertilisers, pharmaceuticals, cosmetics, soaps and detergents
Siegfried plans to grow its exclusive synthesis business in the US by optimizing controlled substance capacity at the Wilmington and nearby Pennsville sites
The trials, which enrolled over 1,000 patients across 398 sites in 17 countries, showed that the drug was safe and well-tolerated—but ultimately failed to deliver the hoped-for clinical results
Lupin’s double ‘A’ rating in Climate and Water exemplifies its steadfast commitment to sustainability
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
This certification paves the way for CORONA's entry into five EAEU member nations- Russia, Kyrgyzstan, Armenia, Belarus, and Kazakhstan-under a B2B business model
Subscribe To Our Newsletter & Stay Updated
